News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Hepatitis B
Additional dose of hepatitis B vaccine improves response in patients with HIV

Hepatitis B vaccination consisting of four doses produces a better response in HIV-positive patients than the standard three-dose vaccination schedule, French investigators report in the April 13th edition

Published
12 April 2011
By
Michael Carter
Hepatitis B
Entecavir and Truvada an option for HBV for treatment-experienced HIV/HBV-co-infected patients

A combination of entecavir with Truvada is an effective and safe option for HIV/hepatitis B-co-infected patients whose current therapy is not suppressing hepatitis B viral load, investigators

Published
30 March 2011
By
Michael Carter
Hepatitis B
Accelerated HBV vaccination schedule an option for HIV patients if CD4 cell count is high

An accelerated hepatitis B vaccination schedule could be an option for HIV-positive patients with a high CD4 cell count, Dutch research published in the April 1st edition

Published
30 March 2011
By
Michael Carter
Cancer
Nanotechnology may lead to new treatment of liver cancer

Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice.

Published
22 February 2011
From
Eurekalert Medicine & Health
Hepatitis and HIV
Good outcomes among HIV-positive patients having a liver transplant due to cancer

HIV-positive patients who have a liver transplant because of liver cancer can have good outcomes, French research published in the February edition of Hepatology shows.  The study

Published
31 January 2011
By
Michael Carter
Hepatitis B
Nucleoside/nucleotide analogue therapy slows liver disease in HIV/HBV-co-infected patients

The progression of liver disease is slowed in patients co-infected with HIV and hepatitis B when their antiretroviral therapy includes drugs that are active against both infections, Spanish

Published
22 November 2010
By
Michael Carter
Hepatitis B
Accelerated hepatitis B vaccine schedule boosts completion rates in IDUs

The proportion of injecting drug users who receive all three doses of the hepatitis B vaccine can be increased using an accelerated vaccination schedule, US investigators report

Published
28 October 2010
By
Michael Carter
Hepatitis B
Abbott receives FDA approval for first automated molecular test for assessing hepatitis B treatment

Abbott announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.

Published
01 September 2010
From
Abbott
Hepatitis B
Vaccination programmes reduce hepatitis B prevalence in the US, but racial disparities persist

Vaccination programmes have reduced the prevalence of hepatitis B amongst children and younger adults in the US, the results of a large study in the

Published
30 June 2010
By
Michael Carter
Hepatitis and HIV
Management of HIV and hepatitis B or C co-infection in resource-limited settings

Review of management of HIV and hepatitis co-infection with particular focus on antiretroviral therapy and liver disease in resource-limited settings.

Published
16 March 2006
From
HIV & AIDS treatment in practice
← Prev1...1516171819Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.